Advancing pediatric drug development in South Asia: Current landscape and vision for the future

IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY
Rajesh Krishna, Manoj Jadhav, Rama Sivasubramanian, Gangadhar Sunkara, Vikram Gota, Vis Niranjan, Vipin Dhote, Nidhi Sapkal, Nirmala N Rege, Samir Sethi, Bikash Medhi, Nilima Kshirsagar, Deven Parmar
{"title":"Advancing pediatric drug development in South Asia: Current landscape and vision for the future","authors":"Rajesh Krishna, Manoj Jadhav, Rama Sivasubramanian, Gangadhar Sunkara, Vikram Gota, Vis Niranjan, Vipin Dhote, Nidhi Sapkal, Nirmala N Rege, Samir Sethi, Bikash Medhi, Nilima Kshirsagar, Deven Parmar","doi":"10.4103/ijp.ijp_396_24","DOIUrl":null,"url":null,"abstract":"<p>The manuscript summarizes the outcomes of a one-day conference by the South Asian College of American College of Clinical Pharmacology (SAC-ACCP) in July 2023, at Bhopal. The theme of the conference was “Advancing pediatric drug development in South Asia.” SAC-ACCP organized this event in Bhopal to foster the discipline of clinical pharmacology and to motivate researchers and physicians in the in the central part of India. The conference featured presentations on regional approaches to pediatric drug development in Asia by pediatric scientific experts from the pharmaceutical industry, regulatory agencies, as well as independent consultancies. The speakers highlighted several important aspects of the evolving regulatory landscape in India and proposed numerous actionable steps in acceleration of pediatric drug development. This commentary provides insights from presentations and the panel discussion at this conference and also makes an attempt to connect to similar discussions that occurred at the SAC-ACCP drug development conference in 2017.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"9 1","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/ijp.ijp_396_24","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

The manuscript summarizes the outcomes of a one-day conference by the South Asian College of American College of Clinical Pharmacology (SAC-ACCP) in July 2023, at Bhopal. The theme of the conference was “Advancing pediatric drug development in South Asia.” SAC-ACCP organized this event in Bhopal to foster the discipline of clinical pharmacology and to motivate researchers and physicians in the in the central part of India. The conference featured presentations on regional approaches to pediatric drug development in Asia by pediatric scientific experts from the pharmaceutical industry, regulatory agencies, as well as independent consultancies. The speakers highlighted several important aspects of the evolving regulatory landscape in India and proposed numerous actionable steps in acceleration of pediatric drug development. This commentary provides insights from presentations and the panel discussion at this conference and also makes an attempt to connect to similar discussions that occurred at the SAC-ACCP drug development conference in 2017.

推动南亚儿科药物开发:当前形势与未来愿景
该手稿总结了美国临床药理学院南亚学院(SAC-ACCP)于 2023 年 7 月在博帕尔举行的为期一天的会议的成果。会议的主题是 "推进南亚儿科药物开发"。SAC-ACCP 在博帕尔举办此次活动的目的是促进临床药理学学科的发展,激励印度中部地区的研究人员和医生。来自制药行业、监管机构和独立咨询机构的儿科科学专家在会上就亚洲儿科药物开发的区域方法作了发言。发言者强调了印度不断变化的监管环境的几个重要方面,并提出了许多加快儿科药物开发的可行步骤。本评论从本次会议的演讲和小组讨论中提出了见解,并试图与 2017 年 SAC-ACCP 药物开发会议上的类似讨论相联系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.00
自引率
4.20%
发文量
53
审稿时长
4-8 weeks
期刊介绍: Indian Journal of Pharmacology accepts, in English, review articles, articles for educational forum, original research articles (full length and short communications), letter to editor, case reports and interesting fillers. Articles concerning all aspects of pharmacology will be considered. Articles of general interest (e.g. methods, therapeutics, medical education, interesting websites, new drug information and commentary on a recent topic) are also welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信